CVE-2023-39949

CVE-2023-39949 is a high-severity vulnerability in Eprosima Fast Dds with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-617.

Key facts

Description

eprosima Fast DDS is a C++ implementation of the Data Distribution Service standard of the Object Management Group. Prior to versions 2.9.1 and 2.6.5, improper validation of sequence numbers may lead to remotely reachable assertion failure. This can remotely crash any Fast-DDS process. Versions 2.9.1 and 2.6.5 contain a patch for this issue.

Frequently asked questions

What is CVE-2023-39949?
eprosima Fast DDS is a C++ implementation of the Data Distribution Service standard of the Object Management Group. Prior to versions 2.9.1 and 2.6.5, improper validation of sequence numbers may lead to remotely reachable assertion failure. This can remotely crash any Fast-DDS process. Versions 2.9.1 and 2.6.5 contain a patch for this issue.
How severe is CVE-2023-39949?
CVE-2023-39949 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity none, and availability high.
Is CVE-2023-39949 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (55th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-39949?
CVE-2023-39949 primarily affects Eprosima Fast Dds. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-39949?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-39949 published?
CVE-2023-39949 was published on 2023-08-11 and last updated on 2026-06-17.

References

Affected products (4)

More vulnerabilities in Eprosima Fast Dds

All CVEs affecting Eprosima Fast Dds →

Other CWE-617 (Reachable Assertion) vulnerabilities

Browse all CWE-617 (Reachable Assertion) vulnerabilities →